Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects.
Open Access
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 48 (8) , 662-666
- https://doi.org/10.1136/ard.48.8.662
Abstract
In a prospective study of 74 patients and a retrospective study of 35 patients with polymyalgia rheumatica/giant cell arteritis steroid related side effects occurred in at least one third of patients, and in two thirds if weight gain was included. Side effects were significantly related to an initial prednisolone dose of more than 30 mg and to the cumulative prednisolone dose. Patients taking a mean daily dose of 5 mg prednisolone or less were significantly less likely to develop side effects.This publication has 21 references indexed in Scilit:
- Polymyalgia rheumatica and corticosteroids: how much for how long?Annals of the Rheumatic Diseases, 1983
- Association of Adrenocorticosteroid Therapy and Peptic-Ulcer DiseaseNew England Journal of Medicine, 1983
- Prognosis and management of polymyalgia rheumatica.Annals of the Rheumatic Diseases, 1981
- Prognosis of Giant Cell Arteritis Including Temporal Arteritis and Polymyalgia RheumaticaActa Medica Scandinavica, 1981
- Treatment and Prognosis in Polymyalgia Rheumatica and Temporal ArteritisActa Medica Scandinavica, 1979
- HLA Antigens and Corticosteroid ResponseScience, 1976
- POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS: A SEVEN-YEAR SURVEYRheumatology, 1975
- THROMBOEMBOLIC COMPLICATIONS DURING CORTICOSTEROID TREATMENT OF TEMPORAL ARTERITISThe Lancet, 1972
- Adrenal glucocorticoids after twenty years: A review of their clinically relevant consequencesJournal of Chronic Diseases, 1970
- Amidines as Adrenergic Neurone Blocking AgentsNature, 1962